These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28723952)

  • 1. Evidence for prehistoric origins of the G2019S mutation in the North African Berber population.
    Ben El Haj R; Salmi A; Regragui W; Moussa A; Bouslam N; Tibar H; Benomar A; Yahyaoui M; Bouhouche A
    PLoS One; 2017; 12(7):e0181335. PubMed ID: 28723952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinson's disease-related LRRK2 G2019S mutation results from independent mutational events in humans.
    Lesage S; Patin E; Condroyer C; Leutenegger AL; Lohmann E; Giladi N; Bar-Shira A; Belarbi S; Hecham N; Pollak P; Ouvrard-Hernandez AM; Bardien S; Carr J; Benhassine T; Tomiyama H; Pirkevi C; Hamadouche T; Cazeneuve C; Basak AN; Hattori N; Dürr A; Tazir M; Orr-Urtreger A; Quintana-Murci L; Brice A;
    Hum Mol Genet; 2010 May; 19(10):1998-2004. PubMed ID: 20197411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNM3 and genetic modifiers of age of onset in LRRK2 Gly2019Ser parkinsonism: a genome-wide linkage and association study.
    Trinh J; Gustavsson EK; Vilariño-Güell C; Bortnick S; Latourelle J; McKenzie MB; Tu CS; Nosova E; Khinda J; Milnerwood A; Lesage S; Brice A; Tazir M; Aasly JO; Parkkinen L; Haytural H; Foroud T; Myers RH; Sassi SB; Hentati E; Nabli F; Farhat E; Amouri R; Hentati F; Farrer MJ
    Lancet Neurol; 2016 Nov; 15(12):1248-1256. PubMed ID: 27692902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 G2019S in the North African population: a review.
    Benamer HT; de Silva R
    Eur Neurol; 2010; 63(6):321-5. PubMed ID: 20413974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of the LRRK2 G2019S mutation in South African patients with Parkinson's disease.
    du Toit N; van Coller R; Anderson DG; Carr J; Bardien S
    Neurogenetics; 2019 Oct; 20(4):215-218. PubMed ID: 31493133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High frequency and reduced penetrance of LRRK2 G2019S mutation among Parkinson's disease patients in Cantabria (Spain).
    Sierra M; González-Aramburu I; Sánchez-Juan P; Sánchez-Quintana C; Polo JM; Berciano J; Combarros O; Infante J
    Mov Disord; 2011 Nov; 26(13):2343-6. PubMed ID: 21954089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs.
    Lesage S; Dürr A; Tazir M; Lohmann E; Leutenegger AL; Janin S; Pollak P; Brice A;
    N Engl J Med; 2006 Jan; 354(4):422-3. PubMed ID: 16436781
    [No Abstract]   [Full Text] [Related]  

  • 10. LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.
    Zabetian CP; Hutter CM; Yearout D; Lopez AN; Factor SA; Griffith A; Leis BC; Bird TD; Nutt JG; Higgins DS; Roberts JW; Kay DM; Edwards KL; Samii A; Payami H
    Am J Hum Genet; 2006 Oct; 79(4):752-8. PubMed ID: 16960813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 G2019S-induced mitochondrial DNA damage is LRRK2 kinase dependent and inhibition restores mtDNA integrity in Parkinson's disease.
    Howlett EH; Jensen N; Belmonte F; Zafar F; Hu X; Kluss J; Schüle B; Kaufman BA; Greenamyre JT; Sanders LH
    Hum Mol Genet; 2017 Nov; 26(22):4340-4351. PubMed ID: 28973664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G2019S LRRK2 mutation in French and North African families with Parkinson's disease.
    Lesage S; Ibanez P; Lohmann E; Pollak P; Tison F; Tazir M; Leutenegger AL; Guimaraes J; Bonnet AM; Agid Y; Dürr A; Brice A;
    Ann Neurol; 2005 Nov; 58(5):784-7. PubMed ID: 16240353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients.
    Bardien S; Marsberg A; Keyser R; Lombard D; Lesage S; Brice A; Carr J
    J Neural Transm (Vienna); 2010 Jul; 117(7):847-53. PubMed ID: 20544233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ashkenazi Parkinson's disease patients with the LRRK2 G2019S mutation share a common founder dating from the second to fifth centuries.
    Bar-Shira A; Hutter CM; Giladi N; Zabetian CP; Orr-Urtreger A
    Neurogenetics; 2009 Oct; 10(4):355-8. PubMed ID: 19283415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India.
    Vijayan B; Gopala S; Kishore A
    Neurol India; 2011; 59(2):157-60. PubMed ID: 21483109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic screening of the G2019S mutation of the LRRK2 gene in Southwest European, North African, and Sephardic Jewish subjects.
    Change N; Mercier G; Lucotte G
    Genet Test; 2008 Sep; 12(3):333-9. PubMed ID: 18666856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Modeling of Leucine-Rich Repeat Kinase 2 G2019S-Mediated Parkinson's Disease Pathology.
    Vermilyea SC; Emborg ME
    Stem Cells Dev; 2018 Jul; 27(14):960-967. PubMed ID: 29402177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leucine rich repeat kinase 2 (LRRK2) GLY2019SER mutation is absent in a second cohort of Nigerian Africans with Parkinson disease.
    Okubadejo NU; Rizig M; Ojo OO; Jonvik H; Oshinaike O; Brown E; Houlden H
    PLoS One; 2018; 13(12):e0207984. PubMed ID: 30507963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.
    Mata IF; Hutter CM; González-Fernández MC; de Pancorbo MM; Lezcano E; Huerta C; Blazquez M; Ribacoba R; Guisasola LM; Salvador C; Gómez-Esteban JC; Zarranz JJ; Infante J; Jankovic J; Deng H; Edwards KL; Alvarez V; Zabetian CP
    Neurogenetics; 2009 Oct; 10(4):347-53. PubMed ID: 19308469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.